Refractory B-cell prolymphocytic leukemia

Clinical trials for Refractory B-cell prolymphocytic leukemia explained in plain language.

Never miss a new study

Get alerted when new Refractory B-cell prolymphocytic leukemia trials appear

Sign up with your email to follow new studies for Refractory B-cell prolymphocytic leukemia, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Triple-Target CAR T-Cells offer new hope for tough blood cancers

Disease control Recruiting now

This early-stage trial tests a new type of cell therapy for people with certain blood cancers (like lymphoma, leukemia) that have returned or stopped responding to standard treatments. The therapy uses a patient's own immune cells, which are genetically modified to recognize and …

Matched conditions: REFRACTORY B-CELL PROLYMPHOCYTIC LEUKEMIA

Phase 1 • Sponsor: Sumithira Vasu • Aim: Disease control

Last updated Jun 27, 2026 13:00 UTC

Refractory B-cell prolymphocytic leukemia

Get alerted when new Refractory B-cell prolymphocytic leukemia trials appear

Triple-Target CAR T-Cells offer new hope for tough blood cancers